Geoffrey Chaiken is co-founder and CEO of Blink Health, launched in February 2016, which allows patients regardless of insurance status to pay for lower-price prescriptions online before picking them up at their preferred pharmacy. He was previously one of three investors at Brave Warrior Advisors, managing $3 billion and leading the firm’s successful investment throughout the technology and pharmaceutical supply chains. Earlier in his career, Chaiken founded Marinus Pharmaceuticals, a specialty pharmaceutical company developing treatments for severe epilepsy where he developed the company’s original strategy, licensed its lead product, and concluded the company’s $30 million series of financing, the largest financing of its kind in Connecticut history.
Previously
The average annual cost of cancer drugs in the US now exceeds $100,000 and the price of more than 200 generic drugs doubled from 2013 to 2014. That puts them far out of reach...